Zhao, Zhihan <br/><br/>
Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  09 2019 
 - 642-651 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1002/cpt.1449  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials--drug effects<br/>Arrhythmias, Cardiac<br/>Cardiovascular Agents--pharmacology<br/>Dose-Response Relationship, Drug<br/>ERG1 Potassium Channel--metabolism<br/>Epinephrine--pharmacology<br/>Heart Conduction System--abnormalities<br/>Heart Defects, Congenital<br/>Humans<br/>Induced Pluripotent Stem Cells--drug effects<br/>Myocytes, Cardiac--drug effects